JSPR - Jasper Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

JSPR is currently covered by 4 analysts with an average price target of $32.62. This is a potential upside of $10.1 (44.85%) from yesterday's end of day stock price of $22.52.

Jasper Therapeutics's activity chart (see below) currently has 3 price targets and 23 ratings on display. The stock rating distribution of JSPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.4% with an average time for these price targets to be met of 106.75 days.

Highest price target for JSPR is $80, Lowest price target is $4, average price target is $32.62.

Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 07-Mar-2024. First documented stock forecast 21-Oct-2021.

Best performing analysts who are covering JSPR - Jasper Therapeutics:

Judah Frommer Michael King Jay Olson Matthew Luchini

Currently out of the existing stock ratings of JSPR, 21 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

80

$57.48 (255.24%)

8

1 months 17 days ago

2/3 (66.67%)

$53.3 (199.63%)

84

Buy

4

$-18.52 (-82.24%)

4

8 months 10 days ago

4/7 (57.14%)

$-9.3 (-69.92%)

169

Buy

6.85

$-15.67 (-69.58%)

6.85

10 months 12 days ago

7/9 (77.78%)

$-9.35 (-57.72%)

174

19

$18.3 (2614.29%)

2 years 6 months 3 days ago

0/1 (0%)

$5.75 (43.40%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JSPR (Jasper Therapeutics) average time for price targets to be met?

On average it took 106.75 days on average for the stock forecasts to be realized with a an average price target met ratio 50.4

Which analyst has the current highest performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on JSPR (Jasper Therapeutics) with a proven track record?

MATTHEW LUCHINI

Which analyst has the most public recommendations on JSPR (Jasper Therapeutics)?

Judah Frommer works at CREDIT SUISSE and has 7 price targets and 5 ratings on JSPR

Which analyst is the currently most bullish on JSPR (Jasper Therapeutics)?

Jay Olson with highest potential upside - $57.48

Which analyst is the currently most reserved on JSPR (Jasper Therapeutics)?

Judah Frommer with lowest potential downside - -$18.52

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?